Regenxbio Inc(RGNX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RGNX Regenxbio Inc

盘前交易 12-19 09:10:08 EST

7.77

-0.70

-8.26%

盘前7.89

+0.12+1.54%

09:01 EST

最高8.60	最低7.54	成交量129.38万
今开8.53	昨收8.47	日振幅12.51%
总市值3.85亿	流通市值3.15亿	总股本4,955万
成交额1,040万	换手率3.19%	流通股本4,060万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RGNX","market":"US","secType":"STK","nameCN":"Regenxbio Inc","latestPrice":7.77,"timestamp":1734555600000,"preClose":8.47,"halted":0,"volume":1293805,"hourTrading":{"tag":"盘前","latestPrice":7.89,"preClose":7.77,"latestTime":"09:01 EST","volume":3296,"amount":26401.428032,"timestamp":1734616890823},"delay":0,"floatShares":40600644,"shares":49545071,"eps":-4.997044,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.7,"latestTime":"12-19 09:10:08 EST","open":8.53,"high":8.6,"low":7.54,"amount":10399540.546652501,"amplitude":0.125148,"askPrice":8.5,"askSize":300,"bidPrice":7.77,"bidSize":197,"shortable":0,"etf":0,"ttmEps":-4.997044,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734618600000},"adr":0,"listingDate":1442462400000,"adjPreClose":7.77,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":7.89,"preClose":7.77,"latestTime":"09:01 EST","volume":3296,"amount":26401.428032,"timestamp":1734616890823},"postHourTrading":{"tag":"盘后","latestPrice":8.11,"preClose":7.77,"latestTime":"17:37 EST","volume":30396,"amount":239975.6701,"timestamp":1734561470450},"volumeRatio":0.9827933587773233,"impliedVol":0.7235,"impliedVolPercentile":0.1514},"requestUrl":"/m/hq/s/RGNX","defaultTab":"news","newsList":[{"id":"2492615587","title":"Regenxbio Inc.盘中异动 下午盘急速下挫5.08%报8.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492615587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492615587?lang=zh_cn&edition=full","pubTime":"2024-12-19 03:55","pubTimestamp":1734551706,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日03时55分，Regenxbio Inc.股票出现异动，股价大幅下挫5.08%。截至发稿，该股报8.04美元/股，成交量61.7948万股，换手率1.25%，振幅6.49%。机构评级方面，在所有11家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为1.91%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219035506984cb777&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219035506984cb777&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","BK4563","RGNX"],"gpt_icon":0},{"id":"2491769078","title":"Regenxbio Inc.盘中异动 股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491769078","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491769078?lang=zh_cn&edition=full","pubTime":"2024-12-16 23:06","pubTimestamp":1734361594,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日23时06分，Regenxbio Inc.股票出现波动，股价大幅上涨5.07%。截至发稿，该股报8.70美元/股，成交量11.3463万股，换手率0.23%，振幅6.82%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为0.47%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216230634ab7ca5be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216230634ab7ca5be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4563","RGNX","BK4139"],"gpt_icon":0},{"id":"2490355861","title":"Regenxbio Inc.盘中异动 早盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490355861","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490355861?lang=zh_cn&edition=full","pubTime":"2024-12-11 23:49","pubTimestamp":1733932145,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日23时49分，Regenxbio Inc.股票出现波动，股价大幅下跌5.02%。截至发稿，该股报9.27美元/股，成交量14.5191万股，换手率0.29%，振幅4.82%。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为0.63%。其相关个股中，Candel Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Protagenic Therapeutics Inc C/Wts 29/04/2026 涨幅较大，Silexion Therapeutics Corp、Candel Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为434.89%、172.98%、102.53%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Candel Therapeutics, Inc.、Biora Therapeutics Inc，振幅分别为127.38%、104.12%、69.68%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211234905ab6ff176&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211234905ab6ff176&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RGNX","BK4563","BK4505"],"gpt_icon":0},{"id":"2490017205","title":"Regenxbio Inc.盘中异动 股价大跌5.70%报9.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490017205","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490017205?lang=zh_cn&edition=full","pubTime":"2024-12-10 22:37","pubTimestamp":1733841453,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日22时37分，Regenxbio Inc.股票出现异动，股价快速下跌5.70%。截至发稿，该股报9.59美元/股，成交量4.4175万股，换手率0.09%，振幅3.05%。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为0.31%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210223734984b0c3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210223734984b0c3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGNX","BK4139","BK4563","BK4505"],"gpt_icon":0},{"id":"2489231032","title":"Regenxbio Inc.盘中异动 早盘股价大涨5.26%报9.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489231032","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489231032?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:13","pubTimestamp":1733497984,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时13分，Regenxbio Inc.股票出现异动，股价急速拉升5.26%。截至发稿，该股报9.20美元/股，成交量5.1662万股，换手率0.10%，振幅6.98%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为0.76%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206231304ab62eb6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206231304ab62eb6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGNX","BK4563","BK4505","BK4139"],"gpt_icon":0},{"id":"2489469290","title":"Regenxbio Inc.盘中异动 早盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489469290","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489469290?lang=zh_cn&edition=full","pubTime":"2024-12-05 23:55","pubTimestamp":1733414143,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日23时55分，Regenxbio Inc.股票出现波动，股价大幅下跌5.02%。截至发稿，该股报8.70美元/股，成交量15.18万股，换手率0.31%，振幅6.22%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为0.44%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205235544ab60268b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205235544ab60268b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4139","RGNX","BK4505"],"gpt_icon":0},{"id":"2488001949","title":"Regenxbio Inc.盘中异动 快速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488001949","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488001949?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:47","pubTimestamp":1733237253,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时47分，Regenxbio Inc.股票出现波动，股价快速跳水5.00%。截至发稿，该股报9.50美元/股，成交量3.1502万股，换手率0.06%，振幅3.60%。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为0.39%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203224734a2699e4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203224734a2699e4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4563","RGNX","BK4139"],"gpt_icon":0},{"id":"2486726708","title":"Regenxbio Inc.盘中异动 早盘急速上涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486726708","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486726708?lang=zh_cn&edition=full","pubTime":"2024-11-28 00:19","pubTimestamp":1732724353,"startTime":"0","endTime":"0","summary":"北京时间2024年11月28日00时19分，Regenxbio Inc.股票出现异动，股价大幅拉升5.20%。截至发稿，该股报10.05美元/股，成交量15.5489万股，换手率0.31%，振幅6.89%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128001913971a8ece&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128001913971a8ece&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGNX","BK4139","BK4563","BK4505"],"gpt_icon":0},{"id":"2486038135","title":"Regenxbio Inc.盘中异动 早盘急速拉升5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486038135","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486038135?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:33","pubTimestamp":1732545227,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时33分，Regenxbio Inc.股票出现异动，股价快速拉升5.21%。截至发稿，该股报10.09美元/股，成交量2.1185万股，换手率0.04%，振幅2.29%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为1.06%。其相关个股中，Scholar Rock Holding Corporation、Bridgebio Pharma, Inc.、Citius Pharmaceuticals, Inc.涨幅较大，Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为87.24%、61.67%、38.71%，振幅较大的相关个股有Anixa Biosciences, Inc.、Werewolf Therapeutics, Inc.、Kodiak Sciences Inc，振幅分别为105.47%、105.26%、105.01%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522334898e4465c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522334898e4465c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGNX","BK4139","BK4563","BK4505"],"gpt_icon":0},{"id":"2485729199","title":"Regenxbio Inc.盘中异动 股价大涨5.56%报9.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485729199","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485729199?lang=zh_cn&edition=full","pubTime":"2024-11-23 01:17","pubTimestamp":1732295848,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日01时17分，Regenxbio Inc.股票出现波动，股价快速拉升5.56%。截至发稿，该股报9.69美元/股，成交量18.0748万股，换手率0.36%，振幅6.59%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为0.72%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112301172998e44350&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112301172998e44350&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGNX","BK4139","BK4563","BK4505"],"gpt_icon":0},{"id":"2485367417","title":"Regenxbio Inc.盘中异动 临近午盘股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485367417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485367417?lang=zh_cn&edition=full","pubTime":"2024-11-22 00:45","pubTimestamp":1732207528,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日00时45分，Regenxbio Inc.股票出现异动，股价快速跳水5.19%。截至发稿，该股报9.13美元/股，成交量22.7325万股，换手率0.46%，振幅5.61%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122004528abd51f52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122004528abd51f52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","RGNX","BK4139","BK4563"],"gpt_icon":0},{"id":"2484341110","title":"Regenxbio Inc.盘中异动 早盘股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484341110","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484341110?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:38","pubTimestamp":1732113480,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时38分，Regenxbio Inc.股票出现异动，股价急速跳水5.13%。截至发稿，该股报9.07美元/股，成交量3.7835万股，换手率0.08%，振幅5.44%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112022380098e43bec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112022380098e43bec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4563","BK4505","RGNX"],"gpt_icon":0},{"id":"2484388923","title":"Regenxbio Inc.盘中异动 急速下挫5.52%报9.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484388923","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484388923?lang=zh_cn&edition=full","pubTime":"2024-11-19 22:31","pubTimestamp":1732026672,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日22时31分，Regenxbio Inc.股票出现波动，股价快速下挫5.52%。截至发稿，该股报9.59美元/股，成交量1.9961万股，换手率0.04%，振幅0.00%。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为0.46%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119223113a245ef7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119223113a245ef7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGNX","BK4139","BK4563","BK4505"],"gpt_icon":0},{"id":"2484960389","title":"美国研究综述-Equifax、Microstrategy、Netflix","url":"https://stock-news.laohu8.com/highlight/detail?id=2484960389","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484960389?lang=zh_cn&edition=full","pubTime":"2024-11-19 15:10","pubTimestamp":1732000212,"startTime":"0","endTime":"0","summary":"美国研究综述-Equifax、Microstrategy、Netflix路透11月19日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Equifax、Microstrategy 和 Netflix。要闻  * 凯斯百货公司CASY.O：杰富瑞将目标价从 450 美元上调至 470 美元 * Equifax Inc EFX.N：摩根大通将目标价从304美元下调至283美元 * Microstrategy Inc MSTR.O：Benchmark将目标价从300美元上调至450美元 * Netflix Inc NFLX.O：杰富瑞将目标价从800美元上调至1000美元 * Palo Alto Networks Inc PANW.O：杰富瑞将目标价从400美元上调至450美元以下是路透周二报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241119:nL4S3MQ0JJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4107","LU2237957902.USD","MRNA","BK4077","LU2326559502.SGD","NFLX","KYMR","CHPT","LU2249611893.SGD","MOS","BK4113","WSM","LU1571399168.USD","VRT","LU1046421795.USD","PTCT","BK4585","PLUG","LU1670710661.SGD","LU0109394709.USD","ACRS","CPRT","FTNT","MSTR","PANW","LOVE","QS","KHC","CPRX","FENC","IDYA","KMPR","RGNX","BECN","LU1429558221.USD","CGEM","CASY","RDDT","CCCC","ARVN","EFX","IE00BQXX3C00.GBP","LU0106261372.USD","DCOM","RC","MEOH","FNV","BK4588","EHAB"],"gpt_icon":1},{"id":"2484676766","title":"Regenxbio Inc.股价飙升11.63% 市值涨6194.25万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484676766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484676766?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:31","pubTimestamp":1731940314,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时31分，Regenxbio Inc.股票出现波动，股价大幅上涨11.63%。截至发稿，该股报10.75美元/股，成交量70.3377万股，换手率1.42%，振幅7.48%。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，Hcw Biologics Inc.、冠科美博、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为516.07%、188.84%、182.52%，振幅较大的相关个股有Hcw Biologics Inc.、冠科美博、Biomx Inc.，振幅分别为33.84%、28.68%、19.34%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822315495be4848&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822315495be4848&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4563","BK4505","RGNX"],"gpt_icon":0},{"id":"2483306018","title":"Regenxbio Inc.2024财年第三财季实现净利润-59.60百万美元，同比增加3.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483306018","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483306018?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686429,"startTime":"0","endTime":"0","summary":"11月16日，Regenxbio Inc.公布财报，公告显示公司2024财年第三财季净利润为-59.60百万美元，同比增加3.67%；其中营业收入为24.20百万美元，同比减少16.29%，每股基本收益为-1.17美元。从资产负债表来看，Regenxbio Inc.总负债2.18亿美元，其中短期债务34.42百万美元，资产负债比为2.39，流动比率为3.04。机构评级：截至2024年11月16日，当前有11家机构对Regenxbio Inc.目标价做出预测，其中目标均价为35.73美元，其中最低目标价为18.00美元，最高目标价为52.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000212abc514b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000212abc514b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGNX"],"gpt_icon":0},{"id":"2483809769","title":"Regenxbio Inc.盘中异动 股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483809769","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483809769?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:31","pubTimestamp":1731594665,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时31分，Regenxbio Inc.股票出现异动，股价急速上涨5.06%。截至发稿，该股报11.21美元/股，成交量2.7996万股，换手率0.06%，振幅4.50%。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为0.42%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114223105971a68b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114223105971a68b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGNX","BK4139","BK4563","BK4505"],"gpt_icon":0},{"id":"2481854189","title":"Regenxbio Inc.盘中异动 早盘急速拉升5.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481854189","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481854189?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:31","pubTimestamp":1730903517,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时31分，Regenxbio Inc.股票出现波动，股价快速拉升5.72%。截至发稿，该股报9.43美元/股，成交量1.0545万股，换手率0.02%，振幅104.76%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为0.91%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223157a21d2a51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223157a21d2a51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGNX","BK4563","BK4505","BK4139"],"gpt_icon":0},{"id":"2479325547","title":"Regenxbio Inc.盘中异动 快速下跌5.05%报8.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479325547","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479325547?lang=zh_cn&edition=full","pubTime":"2024-10-30 03:14","pubTimestamp":1730229267,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日03时14分，Regenxbio Inc.股票出现异动，股价大幅下跌5.05%。截至发稿，该股报8.91美元/股，成交量27.4857万股，换手率0.56%，振幅5.70%。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为0.27%。其相关个股中，Glycomimetics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Lixte Biotechnology Holdings, Inc.涨幅较大，Glycomimetics, Inc.、Lixte Biotechnology Holdings, Inc.、Novabay Pharmaceuticals, Inc.较为活跃，换手率分别为1626.50%、1420.23%、355.86%，振幅较大的相关个股有Glycomimetics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Dermata Therapeutics Inc C/Wts ，振幅分别为183.65%、88.24%、78.31%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030031427971a2ffa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030031427971a2ffa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","RGNX","BK4139","BK4505"],"gpt_icon":0},{"id":"2477898281","title":"Regenxbio Inc.盘中异动 股价大跌5.23%报10.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477898281","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477898281?lang=zh_cn&edition=full","pubTime":"2024-10-22 00:04","pubTimestamp":1729526655,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日00时04分，Regenxbio Inc.股票出现异动，股价急速下挫5.23%。截至发稿，该股报10.52美元/股，成交量25.444万股，换手率0.51%，振幅6.40%。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为0.62%。其相关个股中，Genprex, Inc.、Biovie Inc.、Gri Bio, Inc.涨幅较大，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.较为活跃，换手率分别为6878.47%、3235.29%、1399.63%，振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为369.73%、157.02%、148.15%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102200041598e3d946&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102200041598e3d946&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","RGNX","BK4139","BK4505"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.regenxbio.com","stockEarnings":[{"period":"1week","weight":-0.1645},{"period":"1month","weight":-0.2345},{"period":"3month","weight":-0.3784},{"period":"6month","weight":-0.3536},{"period":"1year","weight":-0.6038},{"period":"ytd","weight":-0.5671}],"compareEarnings":[{"period":"1week","weight":-0.0349},{"period":"1month","weight":-0.0032},{"period":"3month","weight":0.0268},{"period":"6month","weight":0.0767},{"period":"1year","weight":0.2347},{"period":"ytd","weight":0.2335}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Regenxbio Inc.于2008年7月16日成立。该公司是一家领先的生物技术公司，专注于重组腺相关病毒（AAV）基因疗法的发展，商业化和许可。在AAV基因治疗，病毒基因从所述AAV，一个小的非致病性感冒病毒除去，产生所谓的载体的生物递送载体。治疗性基因的序列然后被插入，形成重组载体。该公司专有的AAV基因交付平台（资产净值技术平台）包括专有权超过100新型AAV载体，包括AAV7，AAV8，AAV9和AAVrh10（NAV向量）。公司的使命是将患者的生命从严重的疾病，患有显著未满足的医疗需求，通过开发和商业化直接给予体内基因治疗产品，或者体内，根据其资产净值技术平台上。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.091191},{"month":2,"riseRate":0.333333,"avgChangeRate":0.042372},{"month":3,"riseRate":0.555556,"avgChangeRate":0.007107},{"month":4,"riseRate":0.555556,"avgChangeRate":0.001544},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.016188},{"month":6,"riseRate":0.666667,"avgChangeRate":0.061006},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.005994},{"month":8,"riseRate":0.333333,"avgChangeRate":0.014099},{"month":9,"riseRate":0.555556,"avgChangeRate":0.070275},{"month":10,"riseRate":0.3,"avgChangeRate":-0.099147},{"month":11,"riseRate":0.7,"avgChangeRate":0.17661},{"month":12,"riseRate":0.3,"avgChangeRate":-0.063591}],"exchange":"NASDAQ","name":"Regenxbio Inc","nameEN":"Regenxbio"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Regenxbio Inc(RGNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Regenxbio Inc(RGNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Regenxbio Inc,RGNX,Regenxbio Inc股票,Regenxbio Inc股票老虎,Regenxbio Inc股票老虎国际,Regenxbio Inc行情,Regenxbio Inc股票行情,Regenxbio Inc股价,Regenxbio Inc股市,Regenxbio Inc股票价格,Regenxbio Inc股票交易,Regenxbio Inc股票购买,Regenxbio Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Regenxbio Inc(RGNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Regenxbio Inc(RGNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}